Funding
The study was funded by SGN Nanopharma Inc., 3720 Spectrum Blvd., Suites 125 B&C, Tampa, FL 33612, USA. It was managed, monitored and analysed by JSS Medical Research Asia Pacific Private Limited, Tower 2, 1st Floor, South Wing, L&T Business Park, Sector 27 D, Faridabad−121003, Haryana, India.